标题
New and Emerging Drug Molecules Against Obesity
作者
关键词
-
出版物
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 19, Issue 1, Pages 65-76
出版商
SAGE Publications
发表日期
2013-09-25
DOI
10.1177/1074248413501017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans
- (2013) Benjamin S. Maciejewski et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
- (2013) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II)
- (2013) Caroline M. Apovian et al. Obesity
- Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure
- (2013) Carl J. Lavie et al. JACC-Heart Failure
- Randomized Placebo-Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM-DM Study
- (2012) Patrick M. O'Neil et al. Obesity
- Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
- (2011) W Timothy Garvey et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
- (2011) Silvie Timmers et al. Cell Metabolism
- New Drug Targets for the Treatment of Obesity
- (2011) A G Powell et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
- (2011) Meredith C. Fidler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multiple-Dose Safety, Pharmacokinetics, and Pharmacodynamics of the μ-Opioid Receptor Inverse Agonist GSK1521498
- (2011) Pradeep J. Nathan et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)
- (2011) David B. Allison et al. Obesity
- The anti-angiogenic herbal composition Ob-X fromMorus alba,Melissa officinalis, andArtemisia capillarisregulates obesity in genetically obese ob/ob mice
- (2011) Michung Yoon et al. PHARMACEUTICAL BIOLOGY
- Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial
- (2010) Asem H Ali et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy
- (2010) M A Valentino et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Neuropsychiatric Adverse Effects of Centrally Acting Antiobesity Drugs
- (2010) Pradeep J. Nathan et al. CNS Neuroscience & Therapeutics
- A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
- (2010) L J Aronne et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders
- (2009) David J. Heal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy
- (2009) R Krishna et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Orlistat-Associated Adverse Effects and Drug Interactions
- (2009) Theodosios D Filippatos et al. DRUG SAFETY
- Tesofensine – a novel potent weight loss medicine
- (2009) Sheila A Doggrell EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Obesity and Cardiovascular Disease
- (2009) Carl J. Lavie et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Angiogenesis and development of adipose tissue
- (2009) V. Christiaens et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Weight Loss, HbA1cReduction, and Tolerability of Cetilistat in a Randomized, Placebo-controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)
- (2009) Peter Kopelman et al. Obesity
- Systematic prevention of overweight and obesity in adults: a qualitative and quantitative literature analysis
- (2009) S. Kremers et al. Obesity Reviews
- Population-Based Prevention of Obesity
- (2008) Shiriki K. Kumanyika et al. CIRCULATION
- Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial
- (2008) N Barak et al. INTERNATIONAL JOURNAL OF OBESITY
- Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
- (2008) W. J. Thomsen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Angiogenesis and obesity
- (2007) H. R. Lijnen CARDIOVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation